Robert Besser
02 Aug 2022, 17:13 GMT+10
SACRAMENTO, California: To counter the large jump in the purchase price of insulin used by diabetics, California is moving forward with plans to manufacture the drug.
In the past 30 years, says California residents, the cost of a vial of insulin has increased from $25 to $300.
Some diabetics must inject insulin every day.
"It's as essential as water," said diabetic Chris Noble, as quoted by the Associated Press.
Health care advocates believe that the ability of pharmaceutical companies to monopolize the manufacturing of insulin has resulted in the enormous price increases.
However, as some insulin patents are approaching their expiration dates, California hopes to disrupt the insulin market by manufacturing their own.
In June, after completing a multi-year study, California lawmakers set aside $100 million for the project, with $50 million to be used to develop three types of insulin, with the remaining funding to invest in creating a manufacturing facility.
Though California Governor Gavin Newsom and state lawmakers have not completed all details, they have agreed that a private company will be responsible for the project.
"Nothing epitomizes market failures more than the cost of insulin," Newsom said in a video posted to his Twitter account. "California is now taking matters into our own hands."
Of note, in 1990 the California Department of Public Health developed a treatment for infant botulism - which affects an infant's large intestine and was largely present in California.
Today, California continues manufacturing the treatment.
While there are only some 110 cases of infant botulism reported each year, according to the U.S. Centers for Disease Control and Prevention, one course of California's botulism treatment costs more than $57,000, according to a legislative analysis.
To date, some 7 million people in the United States require insulin to treat their diabetes.
People with Type 1 diabetes must inject themselves with insulin every day.
Currently, only three companies produce most of the world's insulin.
Due to California's large population, it will be able to not only manufacture, but also purchase its less expensive insulin, thus driving down prices nationwide.
"That's why California's market power matters," said Anthony Wright of Health Access California, a consumer advocacy group.
"To a Wall Street investor, driving down the cost of insulin means you might not be able to get your investment back. To California, driving down the price of insulin is a real savings to both taxpayers, as well as to our residents," he said, as quoted by the Associated Press.
"We expect to save hundreds of millions of dollars for California because of this," said Dr. Mark Ghaly, secretary of the California Health and Human Services Agency.
"This gives us an opportunity to create a blueprint for healthcare affordability that has been so far out of reach for states and, frankly, the federal government, and it's really exciting to see where it can go," he added, as reported by the Associated Press.
Get a daily dose of Japan Herald news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Japan Herald.
More InformationWELLINGTON, New Zealand: During his visit to New Zealand, Ambassador Sujiro Seam, Head of the Delegation of the European Union ...
BERLIN, Germany: Highlighting Berlin's increasing focus on assisting in the Indo-Pacific region amidst rising tensions with China over Taiwan, Germany ...
SHANGHAI, China: After a long period of Covid-19 closures, Shanghai has announced that it will reopen all schools, including kindergartens, ...
BEIJING, China: Following a meeting between their foreign ministers, China and Nepal have agreed to build the Trans-Himalayan Multi-Dimensional Connectivity ...
BEIJING, China: Several regions in China experienced temperatures exceeding 40 degrees Celsius, including the major southwestern city of Chongqing.The country's ...
NAYPYIDAW, Myanmar - Sean Turnell, an Australian academic and economic adviser to Myanmar's deposed leader Aung San Suu Kyi, detained ...
NEW YORK CITY, New York: The American hedge fund Third Point has purchased a stake worth some $1 billion in ...
NEW YORK, New York - Investors were divided on Thursday as to where to send U.S. stocks. Jitters about inflation, ...
WELLINGTON, New Zealand: During his visit to New Zealand, Ambassador Sujiro Seam, Head of the Delegation of the European Union ...
BANGKOK, Thailand: Instant noodle makers have asked Thailand to allow them to increase their prices to meet rising costs, which ...
NEW YORK, New York - U.S. industrial stocks interrupted their five-day rally on Wednesday with all the major indices losing ...
BANGKOK, Thailand: Thailand seeks to invest $61.97 billion in its industrial eastern region over the next five years, in a ...